Visit our new Alternative Investment section.Click here

Less Ads, More Data, More Tools Register for FREE

Craneware says US healthcare market evolving as interim profit surges

Mon, 02nd Mar 2026 14:29

(Alliance News) - Craneware PLC on Monday said it has "never been more confident in the vital role we play" in helping its customers handle changes to the US healthcare market.

It also announced a higher interim dividend, as half-year revenue climbed sharply.

The Edinburgh-based software solutions provider said pretax profit jumped 29% to USD13.0 million in the six months to December 31, from USD10.1 million a year ago. Revenue climbed 5.7% to USD105.7 million from USD100.0 million.

Craneware announced an interim dividend of 15.0 pence per share, up 11% from 13.5p a year ago.

Looking ahead, Craneware highlighted "innovation" to "profoundly" impact US healthcare operations, which will drive demand and expand the firm's addressable market.

Further, it said it sees its Microsoft Corp partnership as "proving major benefits to our customers, Craneware and Microsoft."

Chief Executive Officer Keith Neilson said: "The US healthcare market continues to evolve at pace, and with each new piece of legislation or change, the need for data-led insights and a secure and scalable technology partner grows. We have never been more confident in the vital role we play in enabling our customers to navigate these changes with confidence, while maintaining their financial strength and delivery of care. This is a hugely powerful motivator for all of us at The Craneware Group.

"With our wealth of proprietary data, deep industry expertise, longstanding and extensive customer base, and growing AI capabilities, the board looks to the future with confidence."

Craneware shares were 0.6% higher at 1,524.09 pence each on Monday afternoon in London.

By Tom Budszus, Alliance News slot editor

Comments and questions to newsroom@alliancenews.com

Copyright 2026 Alliance News Ltd. All Rights Reserved.

Corporate News Technology Craneware

Shares in this article

Related News

EARNINGS AND TRADING: Tekcapital swings to loss; Abingdon US update
3 hours ago

EARNINGS AND TRADING: Tekcapital swings to loss; Abingdon US update

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately repor...

IN BRIEF: ValiRx subsidiary Cytolytix granted "core" European patent
4 hours ago

IN BRIEF: ValiRx subsidiary Cytolytix granted "core" European patent

ValiRx PLC - London-based life science company - Majority-owned subsidiary Cytolytix Ltd has its European patent "Nanoparticle for Anti-Cancer Peptide...

EARNINGS AND TRADING: GenIP revenue jumps to USD520,000 in 2025
4 hours ago

EARNINGS AND TRADING: GenIP revenue jumps to USD520,000 in 2025

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately repor...

Corporate News Genip Plc + 6 more shares